Palo Alto, California, November 10, 2010 – OroScience plc (Palo Alto, California) will be introducing Curative at the 34th International Dental Show (IDS) from March 22nd to March 26th, 2011. Taking place every two years, IDS in Cologne Germany is the world’s leading international dental trade show, with an anticipated attendance of over 106,000 visitors.
“We believe the commercialization of our oral wound care emulsion, Curative, into the European market represents a significant financial opportunity for OroScience,” said Phil Houle, CEO of OroScience, “and the IDS offers us an excellent opportunity to quickly and effectively introduce Curative to a large number of EU clinicians and distribution partners.”
“We believe Curative addresses a substantial unmet need in oral wound healing, that represents a significant opportunity for OroScience, by offering dentists and their patients a clinically effective therapeutic option for oral wound management,” said Dr. Mark Fontenot, Chairman of OroScience
Curative™ is a new oral wound dressing technology intended to act as a temporary physical barrier, provide moisture and lubrication, and assist the natural process of oral wound healing. Curative™ helps clinicians manage oral wounds by providing a barrier to assist in the process of acute and chronic wound healing. Clinical and animal studies demonstrate that Curative ™ protects and safely promotes the healing of post-operative surgical wounds.
About OroScience
OroScience is a global professional oral care company dedicated to providing advanced therapies for the professional management of oral conditions such as oral wounds and mucositis. Our mission, helping nature heal, is woven into the fabric of OroScience’s organization and vision. In collaboration with leading clinicians, we develop, manufacture, and sell proprietary therapeutic dental and oral care products for oral wound healing, tissue regeneration, and oral disease management.
** END OF PRESS RELEASE **
OroScience plc is an independent, stock exchange listed manufacturer of professional oral care products. This news release may contain certain forward-looking statements, expectations, intentions, strategies and beliefs regarding the future. All statements contained herein are based upon information available to the management of OroScience plc as of the date hereof, and actual results may vary based upon future events, both within and without the control of the management, including risks and uncertainties that could cause actual results to differ materially.
Management does not take any responsibility to update the contents of this News Release in case new aspects arise or new conditions change the facts available.
OroScience plc
Centaurusweg 123
NL 5015 TC Tilburg, Niederlande
ISIN IE00B40WCY19, WKN A0X9H7,
Exchange: Vienna stock exchange, Frankfurt Stock Exchange
Media Contact: OroScience
Phil Houle
Chief Executive Officer
